Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Identifying gene expression signatures for risk stratification of postoperative adjuvant chemotherapy in colorectal cancer
Saved in:
| Published in: | FEBS Open Bio |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Identifying gene expression signatures for risk stratification of postoperative adjuvant chemotherapy in colorectal cancer
- Tumor‐stromal crosstalk and macrophage enrichment are associated with chemotherapy response in bladder cancer
- Glycosylation-Related Gene Signature Identifies MFNG as a Key Driver of Proliferation and Metastasis in Colorectal Cancer
- Repurposing dihydroartemisinin as a novel anticancer agent against colorectal cancer stem cells
- Correction to ‘Cabazitaxel suppresses colorectal cancer cell growth via enhancing the p53 antitumor pathway’
- Machine learning integrated clinical-proteomics data identifies a 6-protein panel signature for atherosclerotic severity and enhanced patient stratification
- Identifying transcription factors controlling the basal expression of human MRP4 highlights a substantial role for Sp1